Cargando…
What have we learned?
As the final outputs of the Reproducibility Project: Cancer Biology are published, it is clear that preclinical research in cancer biology is not as reproducible as it should be.
Autores principales: | Rodgers, Peter, Collings, Andy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8651282/ https://www.ncbi.nlm.nih.gov/pubmed/34874010 http://dx.doi.org/10.7554/eLife.75830 |
Ejemplares similares
-
Pathology of healing: what else might we look at?
por: Horimoto, Yoshiya, et al.
Publicado: (2016) -
COVID-19 and Gynecologic Oncology: What Have We Learned?
por: Leibold, Aurora, et al.
Publicado: (2021) -
Symbiont-mediated cytoplasmic incompatibility: What have we learned in 50 years?
por: Shropshire, J Dylan, et al.
Publicado: (2020) -
Genetic variation in placental insufficiency: What have we learned over time?
por: Wang, Li Qing, et al.
Publicado: (2022) -
Neutrinos, what we have learned about them and what we have learned using them
por: Steinberger, J
Publicado: (2013)